Written Question·Department of Health and Social Care·UIN 54197

Clinical Trials: Standards

Tabled: 21 May 2025

Answered: 2 June 2025

Question

Clive Jones

To ask the Secretary of State for Health and Social Care, what steps the MHRA is taking to improve (a) transparency and (b) predictability for companies seeking UK Market Authorisations.

Answer

Karin Smyth

The Medicines and Healthcare products Regulatory Agency (MHRA) has taken significant steps to improve transparency and predictability for companies seeking United Kingdom market authorisations. This includes clearer guidance, enhanced pre-submission scien...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 54197) →